If you need more lookups,
subscriptions start at $34 USD/month.
Daniel Gottlieb Location
Boston, MA, US
Daniel Gottlieb Work
2019 -now Director @
2019 -now Director @
2020 -now Board of Directors @
2022 -now Board of Directors @
2025 -now Board of Directors @
2019 -now Board of Directors @
2022 -now Board Observer @
2024 -now Board Observer @
2022 -2023 Board Observer @
2019 -2022 Board Observer @
2013 -2019 Vice President, Marketing and Corporate Development @ Proteon Therapeutics
2010 -2013 Senior Director of Marketing and Business Development @ Proteon Therapeutics
2007 -2010 Director of Marketing and Business Development @ Proteon Therapeutics
2006 -2007 Strategic Marketing Manager, Endovascular Business Unit @
2001 -2006 Group Manager, Business Development and Corporate Venture Capital @ Guidant Corporation, Compass Group
1999 -2001 Strategic Planning and Market Research Associate, Coronary Business Unit @
Daniel Gottlieb Education
Dartmouth College
Master Of Business Administration (Management)
1997-1999
University of Pennsylvania
Bachelor Of Arts (Economics, Political Science)
1988-1992
Daniel Gottlieb Skills
Biotechnology
Competitive Analysis
Product Marketing
Product Management
Market Development
Product Launch
Lifesciences
Pharmaceutical Industry
Strategy
CRM
Start-ups
Cross-functional Team Leadership
Business Development
Clinical Development
Strategic Planning
Medical Devices
Market Research
Venture Capital
R&D
Marketing Strategy
Daniel Gottlieb Summary
Daniel Gottlieb, based in Boston, MA, US, is currently a Director at Broadview Ventures Inc. Daniel Gottlieb brings experience from previous roles at Longview Ventures, XII Medical, Cardiosense and Alleviant Medical. Daniel Gottlieb holds a 1997 - 1999 Master Of Business Administration in Management @ Dartmouth College. With a robust skill set that includes Biotechnology, Competitive Analysis, Product Marketing, Product Management, Market Development and more. Daniel Gottlieb has 3 emails on RocketReach.
Looking for a different Daniel Gottlieb?
Find contact details for 700 million professionals.